Rare Cancer News & Clinical Trials » Trial

Trial - CNS Tumor (100 unread)

1 2 3

Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm

Posted: February 1st, 2012, 8:00am MST

Conditions: Mucinous Cystic Tumor With Moderate Dysplasia; Mucinous Cystadenoma of Pancreas; Mucinous Cystadenocarcinoma of Pancreas; Benign Neoplasm of Pancreas
Intervention: Drug: Ethanol and Paclitaxel Injection
Sponsors: Lawson Health Research Institute; University of Western Ontario, Canada
Not yet recruiting - verified February 2012
NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma

Posted: January 26th, 2012, 8:00am MST

Condition: Multiple Myeloma
Intervention: Drug: NOX-A12
Sponsor: Noxxon Pharma AG
Not yet recruiting - verified January 2012
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Posted: January 25th, 2012, 8:00am MST

Conditions: Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Primary Hepatocellular Carcinoma; Chondrosarcoma; Clear Cell Sarcoma of the Kidney; Conjunctival Kaposi Sarcoma; Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; Hormone-resistant Prostate Cancer; Limited Stage Small Cell Lung Cancer; Localized Resectable Adult Primary Liver Cancer; Male Breast Cancer; Mast Cell Sarcoma; Ovarian Sarcoma; Recurrent Adult Brain Tumor; Recurrent Adult Primary Liver Cancer; Recurrent Adult Soft Tissue Sarcoma; Recurrent Bladder Cancer; Recurrent Breast Cancer; Recurrent Colon Cancer; Recurrent Esophageal Cancer; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Gastric Cancer; Recurrent Kaposi Sarcoma; Recurrent Melanoma; Recurrent Non-small Cell Lung Cancer; Recurrent Osteosarcoma; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Prostate Cancer; Recurrent Rectal Cancer; Recurrent Renal Cell Cancer; Recurrent Small Cell Lung Cancer; Recurrent Uterine Sarcoma; Small Intestine Leiomyosarcoma; Stage I Colon Cancer; Stage I Rectal Cancer; Stage I Uterine Sarcoma; Stage IA Breast Cancer; Stage IA Gastric Cancer; Stage IA Ovarian Epithelial Cancer; Stage IA Ovarian Germ Cell Tumor; Stage IB Breast Cancer; Stage IB Gastric Cancer; Stage IB Ovarian Epithelial Cancer; Stage IB Ovarian Germ Cell Tumor; Stage IC Ovarian Epithelial Cancer; Stage IC Ovarian Germ Cell Tumor; Stage II Breast Cancer; Stage II Uterine Sarcoma; Stage IIA Colon Cancer; Stage IIA Gastric Cancer; Stage IIA Non-small Cell Lung Cancer; Stage IIA Ovarian Epithelial Cancer; Stage IIA Ovarian Germ Cell Tumor; Stage IIA Rectal Cancer; Stage IIB Colon Cancer; Stage IIB Esophageal Cancer; Stage IIB Gastric Cancer; Stage IIB Melanoma; Stage IIB Non-small Cell Lung Cancer; Stage IIB Ovarian Epithelial Cancer; Stage IIB Ovarian Germ Cell Tumor; Stage IIB Rectal Cancer; Stage IIC Colon Cancer; Stage IIC Melanoma; Stage IIC Ovarian Epithelial Cancer; Stage IIC Ovarian Germ Cell Tumor; Stage IIC Rectal Cancer; Stage III Uterine Sarcoma; Stage IIIA Breast Cancer; Stage IIIA Colon Cancer; Stage IIIA Esophageal Cancer; Stage IIIA Gastric Cancer; Stage IIIA Melanoma; Stage IIIA Non-small Cell Lung Cancer; Stage IIIA Ovarian Epithelial Cancer; Stage IIIA Ovarian Germ Cell Tumor; Stage IIIA Rectal Cancer; Stage IIIB Breast Cancer; Stage IIIB Colon Cancer; Stage IIIB Esophageal Cancer; Stage IIIB Gastric Cancer; Stage IIIB Melanoma; Stage IIIB Ovarian Epithelial Cancer; Stage IIIB Ovarian Germ Cell Tumor; Stage IIIB Rectal Cancer; Stage IIIC Breast Cancer; Stage IIIC Colon Cancer; Stage IIIC Esophageal Cancer; Stage IIIC Gastric Cancer; Stage IIIC Melanoma; Stage IIIC Ovarian Epithelial Cancer; Stage IIIC Ovarian Germ Cell Tumor; Stage IIIC Rectal Cancer; Stage IV Bladder Cancer; Stage IV Esophageal Cancer; Stage IV Gastric Cancer; Stage IV Melanoma; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IV Uterine Sarcoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: sirolimus; Other: laboratory biomarker analysis; Biological: DEC-205-NY-ESO-1 fusion protein vaccine
Sponsor: Roswell Park Cancer Institute
Not yet recruiting - verified February 2012
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

Posted: January 25th, 2012, 8:00am MST

Conditions: Cholangiocarcinoma; Liver Neoplasms
Interventions: Drug: floxuridine, dexamethasone; Drug: floxuridine, dexamethasone, gemcitabine hydrochloride; Drug: floxuridine, dexamethasone, gemcitabine hydrochloride, oxaliplatin
Sponsor: Washington University School of Medicine
Not yet recruiting - verified January 2012
A Randomized, Double-Blind Trial of Pediatric Lumbar Puncture Under Sedation/Total Intravenous Anesthesia (TIVA) With and Without EMLA Cream

Posted: January 20th, 2012, 8:00am MST

Condition: Hematologic Malignancies
Interventions: Drug: EMLA Cream; Drug: Placebo
Sponsor: Comprehensive Cancer Center of Wake Forest University
Not yet recruiting - verified January 2012
Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Posted: January 19th, 2012, 8:00am MST

Conditions: B-cell Non Hodgkin Lymphoma; Mature B-cell Leukemia Burkitt-type
Interventions: Drug: Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C; Drug: Rituximab, Vincristine, cyclophosphamide, methotrexate, doxorubicin, cytarabine, ara-C
Sponsors: Institut Gustave Roussy; Children's Oncology Group
Recruiting - verified January 2012
Whole Brain Radiation With or Without Erlotinib for Brain Metastases From Non-Small Cell Lung Cancer

Posted: January 19th, 2012, 8:00am MST

Condition: Lung Cancer, Brain Metastases, Radiation Therapy
Interventions: Radiation: Radiation; Drug: Radiation plus erlotinib
Sponsor: Oslo University Hospital
Recruiting - verified January 2012
Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Posted: January 18th, 2012, 8:00am MST

Conditions: Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Interventions: Drug: dalteparin; Drug: lenalidomide; Drug: dexamethasone; Other: laboratory biomarker analysis
Sponsors: USC/Norris Comprehensive Cancer Center; National Cancer Institute (NCI); Celgene Corporation
Recruiting - verified January 2012
Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas

Posted: January 16th, 2012, 8:00am MST

Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide; Drug: veliparib; Genetic: gene expression analysis; Genetic: protein analysis; Other: laboratory biomarker analysis; Other: pharmacological study; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)
Recruiting - verified January 2012
Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma

Posted: January 13th, 2012, 8:00am MST

Condition: Lymphoma
Interventions: Drug: carmustine; Drug: cytarabine; Drug: etoposide; Drug: thiotepa; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsors: Cancer and Leukemia Group B; National Cancer Institute (NCI)
Not yet recruiting - verified January 2012
Breakthrough Dyspnea Fentanyl Study

Posted: January 13th, 2012, 8:00am MST

Conditions: Advanced Cancers; Dyspnea
Interventions: Drug: Fentanyl; Other: Placebo; Other: Walking Tests; Behavioral: Questionnaires
Sponsor: M.D. Anderson Cancer Center
Not yet recruiting - verified January 2012
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Posted: January 13th, 2012, 8:00am MST

Conditions: Prostate Cancer; Castration Resistant Prostate Cancer; Pain; Prostatic Neoplasms
Interventions: Drug: cabozantinib; Drug: mitoxantrone; Drug: prednisone
Sponsor: Exelixis
Recruiting - verified January 2012
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

Posted: January 11th, 2012, 8:00am MST

Conditions: Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Burkitts Leukemia/Lymphoma; Chronic Myelogenous Leukemia
Interventions: Drug: CLAG-M; Drug: CLAG-M
Sponsor: New York Medical College
Recruiting - verified January 2012
PET/CT Imaging of Malignant Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue 124I-NM404

Posted: January 10th, 2012, 8:00am MST

Conditions: Glioblastoma; Brain Metastases NOS
Intervention: Drug: NM404
Sponsors: University of Wisconsin, Madison; National Cancer Institute (NCI)
Recruiting - verified January 2012
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

Posted: January 10th, 2012, 8:00am MST

Conditions: Non-small Cell Lung Cancer; Brain Metastases
Interventions: Drug: icotinib; Radiation: Whole brain radiotherapy
Sponsor: Zhejiang Beta Pharma Inc.
Recruiting - verified January 2012
Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Posted: January 10th, 2012, 8:00am MST

Condition: Leukemia
Interventions: Drug: Interleukin-2; Other: no intervention post-transplantation
Sponsor: Peking University People's Hospital
Recruiting - verified January 2012
Heparin Solution and INTEM/HEPTEM Analysis

Posted: January 9th, 2012, 8:00am MST

Conditions: Brain Tumor; Spinal Stenosis; Cerebral Artery Anuerysm
Intervention: Drug: Heparin
Sponsor: Seoul National University Bundang Hospital
Recruiting - verified January 2012
Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

Posted: January 8th, 2012, 8:00am MST

Condition: Brain Metastasis
Interventions: Drug: Trental; Dietary Supplement: Vitamin E
Sponsor: University of Cincinnati
Recruiting - verified January 2012
Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial

Posted: January 5th, 2012, 8:00am MST

Condition: Uterine Cervical Dysplasia
Interventions: Procedure: Lidocaine spray; Procedure: Lidocaine submucosal injection
Sponsor: Chiang Mai University
Recruiting - verified January 2012
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)

Posted: January 4th, 2012, 8:00am MST

Conditions: Acute Lymphoblastic Leukemia; Neuropathy; Neuropathic Pain
Interventions: Drug: gabapentin; Drug: placebo
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified January 2012
Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffein, Midazolam, and Digoxin in Cancer Subjects

Posted: January 4th, 2012, 8:00am MST

Condition: Solid Tumors
Interventions: Drug: tivantinib; Drug: omeprazole; Drug: s-warfarin; Drug: caffeine; Dietary Supplement: vitamin K; Drug: digoxin; Drug: midazolam
Sponsors: Daiichi Sankyo Inc.; Medpace, Inc.
Recruiting - verified January 2012
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

Posted: January 4th, 2012, 8:00am MST

Conditions: Rhabdomyosarcoma and Other Soft Tissue Sarcomas; Ewing's Sarcoma Family of Tumors; Osteosarcoma; Neuroblastoma; Brain Tumors
Interventions: Drug: sorafenib; Drug: irinotecan
Sponsor: Children's Research Institute
Recruiting - verified January 2012
Rhinological Outcomes in Endonasal Pituitary Surgery

Posted: January 3rd, 2012, 8:00am MST

Conditions: Pituitary Neoplasm; Pituitary Adenoma; Rathke's Cleft Cyst; Cushings Disease; Acromegaly
Intervention:
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Recruiting - verified January 2012
Community Network Program

Posted: January 3rd, 2012, 8:00am MST

Condition: Psychosocial Problem
Interventions: Behavioral: Health Education; Behavioral: Questionnaires; Behavioral: Telephone Counseling Sessions; Drug: Nicotine Patches
Sponsors: M.D. Anderson Cancer Center; National Institutes of Health (NIH)
Recruiting - verified January 2012
Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Posted: January 1st, 2012, 8:00am MST

Condition: Lung Cancer
Intervention: Drug: Celecoxib
Sponsor: Chinese Academy of Medical Sciences
Recruiting - verified January 2012
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy

Posted: December 30th, 2011, 8:00am MST

Conditions: Brain and Central Nervous System Tumors; Cognitive/Functional Effects; Neurotoxicity; Psychosocial Effects of Cancer and Its Treatment; Radiation Toxicity
Interventions: Other: computer-assisted cognitive training; Other: questionnaire administration; Procedure: cognitive assessment; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified December 2011
Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)

Posted: December 30th, 2011, 8:00am MST

Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone; Drug: Placebo
Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
Not yet recruiting - verified January 2012
Convection-Enhanced Delivery of 124I-8H9 for Patients With Non-Progressive Diffuse Pontine Gliomas Previously Treated With External Beam Radiation Therapy

Posted: December 29th, 2011, 8:00am MST

Conditions: Brain Cancer; Brain Stem Glioma
Intervention: Radiation: Radioactive iodine-labeled monoclonal antibody 8H9
Sponsors: Memorial Sloan-Kettering Cancer Center; Weill Medical College of Cornell University; Johns Hopkins University
Recruiting - verified January 2012
$Permalink for 'Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens'$
Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens

Posted: December 27th, 2011, 8:00am MST

Condition: Multiple Myeloma
Intervention: Drug: Vorinostat, Lenalinomide and Dexamethasone
Sponsors: Hackensack University Medical Center; Merck Sharp & Dohme Corp., Inc.
Recruiting - verified December 2011
Maintenance Plasma Exchange for Neuromyelitis Optica

Posted: December 23rd, 2011, 8:00am MST

Conditions: Neuromyelitis Optica; Neuromyelitis Optica Spectrum Disorder; Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis
Intervention: Procedure: Plasma exchange (PLEX)
Sponsors: Mayo Clinic; CaridianBCT
Not yet recruiting - verified December 2011
Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

Posted: December 22nd, 2011, 8:00am MST

Conditions: Gastrointestinal Cancer; Nausea Post Chemotherapy
Intervention: Drug: fosaprepitant dimeglumine
Sponsors: Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)
Not yet recruiting - verified January 2012
Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma

Posted: December 21st, 2011, 8:00am MST

Conditions: Central Nervous System Malignancies; Ependymoma
Intervention: Drug: 5-fluorouracil
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified December 2011
GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Posted: December 20th, 2011, 8:00am MST

Condition: Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
Intervention: Drug: GRN1005
Sponsor: Geron Corporation
Recruiting - verified January 2012
$Permalink for 'Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL)'$
Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL)

Posted: December 20th, 2011, 8:00am MST

Conditions: Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Interventions: Drug: High Dose Methylprednisolone; Drug: Ofatumumab; Drug: Lenalidomide; Drug: Sargramostim
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; GlaxoSmithKline; Celgene Corporation
Recruiting - verified January 2012
$Permalink for 'Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma'$
Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Posted: December 20th, 2011, 8:00am MST

Condition: Multiple Myeloma
Interventions: Drug: Pomalidomide; Drug: Bortezomib; Drug: Dexamethasone
Sponsors: Celgene Corporation; Multiple Myeloma Research Consortium
Recruiting - verified January 2012
Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite

Posted: December 20th, 2011, 8:00am MST

Condition: Anorexia
Interventions: Drug: megestrol acetate; Drug: Arm B (megestrol plus mirtazapine)
Sponsor: Washington University School of Medicine
Not yet recruiting - verified December 2011
Dexmedetomidine on Intraoperative Somatosensory and Motor Evoked Potential Monitoring During Neurosurgery in Pediatric Patients

Posted: December 19th, 2011, 8:00am MST

Conditions: Tethered Spinal Cord; Brain Tumor; Cranio Cervical Compression
Intervention: Other: Isoflurane, Propofol, Dexmedetomidine
Sponsor: Oregon Health and Science University
Recruiting - verified January 2012
Carfilzomib for Relapsed and Unresponsive Multiple Myeloma

Posted: December 16th, 2011, 8:00am MST

Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib; Drug: Carfilzomib; Drug: Carfilzomib; Drug: Dexamethasone; Drug: Dexamethasone
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2011
Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Posted: December 16th, 2011, 8:00am MST

Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Interventions: Drug: High Dose Methylprednisolone; Drug: Ofatumumab; Drug: Lenalidomide; Drug: Sargramostim
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; GlaxoSmithKline; Celgene Corporation
Recruiting - verified January 2012
Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy

Posted: December 16th, 2011, 8:00am MST

Condition: Multiple Myeloma
Interventions: Drug: Vorinostat; Drug: Lenalidomide; Drug: Dexamethasone; Drug: Lenalidomide; Drug: Dexamethasone
Sponsor: University of Turin, Italy
Not yet recruiting - verified December 2011
Two Step Versus the Standard Three Step Approach of the WHO Analgesic Ladder for Cancer Pain Relief.

Posted: December 15th, 2011, 8:00am MST

Conditions: Cancer; Pain
Interventions: Other: analgesic ladder; Other: analgesic ladder
Sponsors: University of Edinburgh; NHS Lothian
Not yet recruiting - verified November 2011
Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenols

Posted: December 15th, 2011, 8:00am MST

Condition: Carcinoma, Squamous Cell
Interventions: Drug: Aspirin; Dietary Supplement: Tea Polyphenols
Sponsor: Beijing Friendship Hospital
Not yet recruiting - verified December 2011
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy

Posted: December 14th, 2011, 8:00am MST

Conditions: Fallopian Tube Cancer; Fatigue; Neuropathy; Neurotoxicity; Ovarian Cancer; Pain; Primary Peritoneal Cavity Cancer
Interventions: Dietary Supplement: acetyl-L-carnitine hydrochloride; Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel; Other: placebo
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified December 2011
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

Posted: December 14th, 2011, 8:00am MST

Condition: Breast Cancer
Interventions: Drug: HKI-272; Drug: HKI-272; Procedure: Surgical Resection
Sponsors: Dana-Farber Cancer Institute; Translational Breast Cancer Research Consortium
Not yet recruiting - verified December 2011
Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management.

Posted: December 12th, 2011, 8:00am MST

Conditions: Uterine Myoma; Persistent Post-menpausal Bleeding; Uterine Cancer
Interventions: Drug: Normal saline; Drug: Intravenous Lidocaine; Drug: Intra-abdominal Lidocaine
Sponsor: Örebro University, Sweden
Recruiting - verified December 2011
Anti-inflammatory and Antioxidant Effects of Resveratrol on Healthy Adults.

Posted: December 12th, 2011, 8:00am MST

Conditions: Chronic Subclinic Inflammation; Redox Status
Interventions: Dietary Supplement: Resveratrol; Dietary Supplement: resveratrol
Sponsor: University of Turin, Italy
Recruiting - verified December 2011
Photoacoustic Endoscopy in Endometrial Cancer

Posted: December 12th, 2011, 8:00am MST

Conditions: Endometrial Cancer; Benign Neoplasm of Body of Uterus
Interventions: Device: Photoacoustic endoprobe; Procedure: Photoacoustic endoscopy
Sponsor: Washington University School of Medicine
Not yet recruiting - verified December 2011
Quality Study of Anesthetic Technique on Breast Cancer Surgery

Posted: December 10th, 2011, 8:00am MST

Conditions: Postoperative Pain; Quality of Recovery; Satisfaction
Intervention: Other: PVB
Sponsor: Nai Liang Li
Not yet recruiting - verified December 2011
Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Posted: December 8th, 2011, 8:00am MST

Conditions: Sarcoma; Chemotherapy-induced Nausea and Vomiting; Effects of Chemotherapy; Adverse Effects of Medical Drugs
Interventions: Drug: Fosaprepitant; Drug: Dexamethasone; Drug: 5HT3 receptor antagonist; Drug: Ifosfamide-based chemotherapy (AI); Drug: Doxorubicin; Drug: Mesna; Drug: Ifosfamide; Drug: Vincristine
Sponsors: M.D. Anderson Cancer Center; Merck
Not yet recruiting - verified December 2011
A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

Posted: December 7th, 2011, 8:00am MST

Condition: Solid Tumour
Intervention: Drug: Dexanabinol
Sponsor: e-Therapeutics PLC
Not yet recruiting - verified January 2012
Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer

Posted: December 7th, 2011, 8:00am MST

Conditions: Colonic Cancer; Metastasis
Interventions: Drug: Oral complex C3 curcumin + chemotherapy; Drug: Chemotherapy only
Sponsor: University of Leicester
Not yet recruiting - verified December 2011
Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma

Posted: December 6th, 2011, 8:00am MST

Condition: Hepatocellular Carcinoma
Interventions: Drug: Drug-Eluting Beads with Doxorubicin; Drug: Lipiodol ethanol mixture
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified February 2012
Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)

Posted: December 6th, 2011, 8:00am MST

Condition: Polycystic Ovary Syndrome
Interventions: Drug: Salsalate; Drug: Salsalate
Sponsor: Indiana University
Not yet recruiting - verified December 2011
Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma

Posted: December 6th, 2011, 8:00am MST

Condition: Urothelial Carcinoma
Interventions: Drug: Pemetrexed; Drug: Cisplatin; Drug: Dexamethasone; Drug: Vitamins
Sponsors: Asan Medical Center; Korea Association for Clinical Oncology
Recruiting - verified December 2011
The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer

Posted: December 5th, 2011, 8:00am MST

Condition: Castration-resistant Prostate Cancer
Interventions: Drug: ADT; Drug: No ADT
Sponsor: Asan Medical Center
Recruiting - verified December 2011
The EC90 of Remifentanil Blunting Hemodynamic Changes to Head Fixation

Posted: December 5th, 2011, 8:00am MST

Conditions: Brain Tumor; AVM; ICH
Intervention: Drug: remifentanil
Sponsor: Seoul National University Hospital
Recruiting - verified December 2011
A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer

Posted: December 4th, 2011, 8:00am MST

Condition: Small Cell Lung Cancer
Intervention: Drug: Lithium
Sponsors: Barwon Health; Victorian Cancer Agency
Not yet recruiting - verified December 2011
$Permalink for 'A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma'$
A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma

Posted: December 2nd, 2011, 8:00am MST

Condition: Multiple Myeloma
Intervention: Drug: Ganetespib+/- Bortezomib +/- Dexamethasone
Sponsors: Emory University; Multiple Myeloma Research Consortium
Not yet recruiting - verified December 2011
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Posted: December 1st, 2011, 8:00am MST

Condition: Glabellar Frown Lines
Intervention: Biological: MT10109
Sponsor: Medy-Tox
Recruiting - verified December 2011
Compare Propofol to Fentanyl and Midazolam for Colonoscopy

Posted: December 1st, 2011, 8:00am MST

Conditions: Colon Cancer; Rectal Cancer; Colonic Diverticulosis
Interventions: Drug: Fentanyl; Drug: Propofol; Drug: Midazolam
Sponsor: Saint Joseph Mercy Health System
Recruiting - verified December 2011
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

Posted: November 29th, 2011, 8:00am MST

Conditions: Acute Lymphoblastic Leukemia; Precursor B-Cell Lymphoblastic Leukemia; Precursor T-Cell Lymphoblastic Leukemia
Interventions: Drug: Decitabine; Drug: Vorinostat; Drug: Vincristine; Drug: Dexamethasone; Drug: Mitoxantrone; Drug: Pegaspargase; Drug: Methotrexate
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Not yet recruiting - verified November 2011
Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ

Posted: November 29th, 2011, 8:00am MST

Condition: Nasal and Nasal-type NK/T-cell Lymphoma
Interventions: Drug: DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase); Drug: Modified SMILE （MTX，DEX，IFO，L-ASP，Etoposide，Mesna）
Sponsors: Mingzhi Zhang; The Second Hospital of Shanxi Medical University; Cancer hospital of shanxi province; Wuhan University; Wuhan TongJi hospital; Wuhan Union Hospital, China; Qingdao Medical University Hospital; Guizhou Cancer Hospital; Central Hospital Of Xinxiang; The First Affiliated Hospital of He'nan University of Science and Technology
Recruiting - verified January 2012
Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma

Posted: November 28th, 2011, 8:00am MST

Condition: Multiple Myeloma
Interventions: Drug: Bendamustine; Drug: Bortezomib; Drug: Lenalidomide; Drug: Dexamethasone
Sponsor: Loyola University
Recruiting - verified December 2011
Treatment of Natural Killer/T Cell Lymphoma-I/II

Posted: November 25th, 2011, 8:00am MST

Condition: Nasal and Nasal-type NK/T-cell Lymphoma
Interventions: Other: DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase); Other: VIPD（cisplatin，Etoposide，Ifosfamide， dexamethasone，Mesna）; Other: gemcitabine,pegaspargase,cisplatin,dexamethasone; Other: cisplatin,Etoposide,Ifosfamide,dexamethasone,Mesna; Radiation: Radiotherapy
Sponsors: Mingzhi Zhang; The Second Hospital of Shanxi Medical University; Cancer hospital of shanxi province; Wuhan University; Wuhan TongJi hospital; Wuhan Union Hospital, China; Qingdao Medical University Hospital; Guizhou Cancer Hospital; Central Hospital Of Xinxiang; The First Affiliated Hospital of He'nan University of Science and Technology
Recruiting - verified January 2012
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Posted: November 23rd, 2011, 8:00am MST

Condition: Brain and Central Nervous System Tumors
Interventions: Drug: mibefradil dihydrochloride; Drug: temozolomide; Other: 3'-deoxy-3'-[18F]fluorothymidine; Other: pharmacological study
Sponsor: National Cancer Institute (NCI)
Not yet recruiting - verified November 2011
A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 in Pretreated Patients With Stage IV Melanoma

Posted: November 23rd, 2011, 8:00am MST

Condition: Malignant Melanoma
Interventions: Drug: Interleukin-2; Drug: Ipilimumab
Sponsor: University Hospital Tuebingen
Not yet recruiting - verified December 2011
ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

Posted: November 21st, 2011, 8:00am MST

Condition: Multiple Myeloma
Interventions: Drug: Doxorubicin; Drug: Bortezomib; Drug: Lenalidomide; Drug: Dexamethasone; Drug: Cyclophosphamide
Sponsors: Vejle Hospital; The University of Hong Kong
Recruiting - verified November 2011
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

Posted: November 21st, 2011, 8:00am MST

Conditions: Familial Adenomatous Polyposis; Attenuated Familial Adenomatous Polyposis
Interventions: Drug: Eflornithine plus Sulindac; Drug: Eflornithine and Placebo; Drug: Sulindac and Placebo
Sponsor: Cancer Prevention Pharmaceuticals, Inc.
Not yet recruiting - verified November 2011
Cerebral Blood Circulation in Patients With Posterior Fossa Brain Tumor

Posted: November 18th, 2011, 8:00am MST

Condition: Brain Tumor
Intervention: Other: Monitoring
Sponsor: All India Institute of Medical Sciences, New Delhi
Not yet recruiting - verified November 2011
Autologous T Cells, Low-Dose Recombinant Interferon Gamma, Cyclophosphamide, and Low-Dose Aldesleukin in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery

Posted: November 17th, 2011, 8:00am MST

Conditions: Adult Liposarcoma; Adult Synovial Sarcoma; Recurrent Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma
Interventions: Biological: recombinant interferon gamma; Biological: aldesleukin; Drug: cyclophosphamide; Other: laboratory biomarker analysis; Procedure: biopsy; Biological: NY-ESO-1-specific T lymphocytes
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Recruiting - verified January 2012
GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases

Posted: November 16th, 2011, 8:00am MST

Conditions: Breast Cancer; Brain Metastases
Interventions: Drug: GRN1005; Drug: Trastuzumab
Sponsor: Geron Corporation
Recruiting - verified January 2012
$Permalink for 'Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma'$
Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Refractory Myeloma

Posted: November 16th, 2011, 8:00am MST

Condition: Multiple Myeloma
Intervention: Drug: ABT-888/Bortezomib
Sponsors: Alberta Health Services; Tom Baker Cancer Centre; Abbott
Recruiting - verified December 2011
Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?

Posted: November 15th, 2011, 8:00am MST

Conditions: Cushing's Syndrome; Adrenal Incidentalomas
Intervention:
Sponsor: Haukeland University Hospital
Recruiting - verified January 2012
ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors

Posted: November 14th, 2011, 8:00am MST

Conditions: Glioma; Metastatic Brain Cancer
Intervention: Device: ExAblate Transcranial System
Sponsor: InSightec
Recruiting - verified November 2011
Intravenous Acetaminophen for Craniotomy Patients

Posted: November 9th, 2011, 8:00am MST

Condition: Craniotomy
Interventions: Drug: Acetaminophen; Other: No acetaminophen
Sponsors: Swedish Medical Center; Cadence Pharmaceuticals
Recruiting - verified November 2011
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors

Posted: November 9th, 2011, 8:00am MST

Condition: Neuroendocrine Tumor
Intervention: Dietary Supplement: Resveratrol
Sponsor: University of Wisconsin, Madison
Recruiting - verified December 2011
The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

Posted: November 8th, 2011, 8:00am MST

Condition: Mucinous Pancreatic Cysts
Interventions: Drug: Ethanol; Drug: Normal Saline; Drug: Chemotherapy
Sponsor: Milton S. Hershey Medical Center
Recruiting - verified November 2011
Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)

Posted: November 4th, 2011, 8:00am MDT

Condition: Brain Cancer
Intervention: Radiation: Radiation Therapy
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified December 2011
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Posted: November 4th, 2011, 8:00am MDT

Conditions: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
Sponsor: Tocagen Inc.
Recruiting - verified January 2012
Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

Posted: November 4th, 2011, 8:00am MDT

Conditions: Macular Edema; Cystoid Macular Edema; Uveal Melanoma; Radiation Maculopathy; Radiation Retinopathy
Intervention: Drug: Ozurdex (Dexamethasone intravitreal implant )
Sponsors: Arman Mashayekhi; Allergan
Not yet recruiting - verified November 2011
Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes

Posted: November 4th, 2011, 8:00am MDT

Condition: Smoking Cessation
Interventions: Other: standard care; Other: standard care plus contingency management
Sponsor: Yale University
Recruiting - verified November 2011
$Permalink for 'Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma'$
Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

Posted: November 2nd, 2011, 8:00am MDT

Condition: Multiple Myeloma
Interventions: Biological: Elotuzumab; Drug: Bortezomib; Drug: Dexamethasone; Drug: Dexamethasone; Drug: Dexamethasone; Drug: Dexamethasone
Sponsors: Bristol-Myers Squibb; Abbott Biotherapeutics
Recruiting - verified November 2011
$Permalink for 'Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma'$
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Posted: October 27th, 2011, 8:00am MDT

Condition: Brain and Central Nervous System Tumors
Interventions: Drug: sunitinib malate; Genetic: gene expression analysis; Genetic: protein expression analysis; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified October 2011
$Permalink for 'A Safety Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma'$
A Safety Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Posted: October 19th, 2011, 8:00am MDT

Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib; Drug: Pomalidomide; Drug: Dexamethasone
Sponsors: Academic Myeloma Consortium; CORE Science Solutions; Onyx Pharmaceuticals; Celgene Corporation
Recruiting - verified December 2011
FUS1-nanoparticles and Erlotinib in Stage IV Lung Cancer

Posted: October 17th, 2011, 8:00am MDT

Condition: Lung Cancer
Interventions: Drug: DOTAP:Chol-fus1; Drug: Erlotinib; Drug: Dexamethasone; Drug: Diphenhydramine
Sponsors: M.D. Anderson Cancer Center; Convergen LifeSciences, Inc.
Not yet recruiting - verified December 2011
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Posted: September 30th, 2011, 8:00am MDT

Condition: Radiation Therapy
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2011
Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments

Posted: September 30th, 2011, 8:00am MDT

Conditions: HIV Infections; Central Nervous System Neoplasms; Neurofibromatosis 1
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified September 2011
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases

Posted: September 30th, 2011, 8:00am MDT

Conditions: Brain Metastasis; Cancer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2011
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas

Posted: September 13th, 2011, 8:00am MDT

Conditions: Brain Neoplasms; Central Nervous System Neoplasms
Interventions: Drug: Everolimus; Drug: Sorafenib
Sponsors: M.D. Anderson Cancer Center; Bayer; Novartis
Not yet recruiting - verified February 2012
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice Multidetector-Row CT Datasets Obtained From the Central Nervous System, Thorax, and Abdomen

Posted: September 7th, 2011, 8:00am MDT

Conditions: Pathology of Posterior Fossa; Lung Cancer; Flank Pain; Urolithiasis; Focal Liver Lesion
Intervention:
Sponsors: GE Healthcare; American College of Radiology - Image Metrix
Recruiting - verified January 2012
Phase I Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin for Post-Radiation Therapy (RT) Glioblastoma Multiforme (GBM)

Posted: September 6th, 2011, 8:00am MDT

Condition: Brain Cancer
Interventions: Drug: Temozolomide; Drug: Memantine; Drug: Mefloquine; Drug: Metformin
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified January 2012
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction

Posted: August 18th, 2011, 8:00am MDT

Conditions: Breast Neoplasms; Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases
Interventions: Drug: Botulinum Toxin Type A; Drug: 0.9% Sodium Chloride
Sponsors: University of British Columbia; Vancouver Coastal Health; Providence Health & Services
Recruiting - verified January 2012
Managing Medication-induced Constipation in Cancer: A Clinical Trial

Posted: August 11th, 2011, 8:00am MDT

Condition: Constipation
Interventions: Other: Opioid Dose Intervention; Other: Opioid Assessment Intervention; Other: Vinca Alkaloid Assessment Intervention
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; National Institutes of Health (NIH); University of South Florida
Recruiting - verified January 2012
Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma

Posted: August 11th, 2011, 8:00am MDT

Condition: Multiple Myeloma
Interventions: Drug: GSK2110183; Drug: Bortezomib; Drug: Dexamethasone
Sponsor: GlaxoSmithKline
Recruiting - verified January 2012
Multimodal Therapy for Treatment of Fatigue

Posted: August 4th, 2011, 8:00am MDT

Condition: Prostate Cancer
Interventions: Other: Placebo; Drug: Methylphenidate; Behavioral: Counseling Sessions; Other: Sham Exercise; Other: Standardized Exercise Intervention Program; Other: Cognitive Behavioral Therapy (CBT)
Sponsors: M.D. Anderson Cancer Center; American Cancer Society
Not yet recruiting - verified January 2012
Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin

Posted: August 2nd, 2011, 8:00am MDT

Condition: Leukemia
Interventions: Drug: ATRA; Drug: ATO; Drug: GO (Gemtuzumab ozogamicin); Drug: Methylprednisolone
Sponsors: M.D. Anderson Cancer Center; Pfizer
Recruiting - verified December 2011
Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

Posted: July 27th, 2011, 8:00am MDT

Condition: Acute Promyelocytic Leukemia
Intervention: Drug: Tretinoin and Arsenic Trioxide
Sponsors: Memorial Sloan-Kettering Cancer Center; Northwestern University; New York Presbyterian Hospital; University of Southern California; Princess Margaret Hospital, Canada; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

Posted: July 23rd, 2011, 8:00am MDT

Condition: Multiple Myeloma
Interventions: Drug: Carfilzomib; Drug: Lenalidomide; Drug: Dexamethasone
Sponsors: National Cancer Institute (NCI); Celgene Corporation; Onyx Therapeutics, Inc.
Recruiting - verified July 2011
Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Posted: July 20th, 2011, 8:00am MDT

Conditions: Chemotherapeutic Agent Toxicity; Cognitive/Functional Effects; Lymphoma; Neurotoxicity; Radiation Toxicity
Interventions: Biological: rituximab; Drug: cytarabine; Drug: methotrexate; Drug: procarbazine hydrochloride; Drug: vincristine sulfate; Radiation: whole-brain radiation therapy
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Recruiting - verified January 2012
Safety and Imaging Study of GC1008 in Glioma

Posted: July 18th, 2011, 8:00am MDT

Condition: Primary Brain Tumors
Interventions: Other: 89Zr-GC1008; Drug: GC1008
Sponsors: University Medical Centre Groningen; Genzyme
Recruiting - verified January 2012

1 2 3

← Trial - Brain Tumor Trial - Ganglioglioma →

Rare Cancer News & Clinical Trials » Trial - CNS Tumor

Feeds

Trial - CNS Tumor (100 unread)

Posted: February 1st, 2012, 8:00am MST

Posted: January 26th, 2012, 8:00am MST

Posted: January 25th, 2012, 8:00am MST

Posted: January 25th, 2012, 8:00am MST

Posted: January 20th, 2012, 8:00am MST

Posted: January 19th, 2012, 8:00am MST

Posted: January 19th, 2012, 8:00am MST

Posted: January 18th, 2012, 8:00am MST

Posted: January 16th, 2012, 8:00am MST

Posted: January 13th, 2012, 8:00am MST

Posted: January 13th, 2012, 8:00am MST

Posted: January 13th, 2012, 8:00am MST

Posted: January 11th, 2012, 8:00am MST

Posted: January 10th, 2012, 8:00am MST

Posted: January 10th, 2012, 8:00am MST

Posted: January 10th, 2012, 8:00am MST

Posted: January 9th, 2012, 8:00am MST

Posted: January 8th, 2012, 8:00am MST

Posted: January 5th, 2012, 8:00am MST

Posted: January 4th, 2012, 8:00am MST

Posted: January 4th, 2012, 8:00am MST

Posted: January 4th, 2012, 8:00am MST

Posted: January 3rd, 2012, 8:00am MST

Posted: January 3rd, 2012, 8:00am MST

Posted: January 1st, 2012, 8:00am MST

Posted: December 30th, 2011, 8:00am MST

Posted: December 30th, 2011, 8:00am MST

Posted: December 29th, 2011, 8:00am MST

Posted: December 27th, 2011, 8:00am MST

Posted: December 23rd, 2011, 8:00am MST

Posted: December 22nd, 2011, 8:00am MST

Posted: December 21st, 2011, 8:00am MST

Posted: December 20th, 2011, 8:00am MST

Posted: December 20th, 2011, 8:00am MST

Posted: December 20th, 2011, 8:00am MST

Posted: December 20th, 2011, 8:00am MST

Posted: December 19th, 2011, 8:00am MST

Posted: December 16th, 2011, 8:00am MST

Posted: December 16th, 2011, 8:00am MST

Posted: December 16th, 2011, 8:00am MST

Posted: December 15th, 2011, 8:00am MST

Posted: December 15th, 2011, 8:00am MST

Posted: December 14th, 2011, 8:00am MST

Posted: December 14th, 2011, 8:00am MST

Posted: December 12th, 2011, 8:00am MST

Posted: December 12th, 2011, 8:00am MST

Posted: December 12th, 2011, 8:00am MST

Posted: December 10th, 2011, 8:00am MST

Posted: December 8th, 2011, 8:00am MST

Posted: December 7th, 2011, 8:00am MST

Posted: December 7th, 2011, 8:00am MST

Posted: December 6th, 2011, 8:00am MST

Posted: December 6th, 2011, 8:00am MST

Posted: December 6th, 2011, 8:00am MST

Posted: December 5th, 2011, 8:00am MST

Posted: December 5th, 2011, 8:00am MST

Posted: December 4th, 2011, 8:00am MST

Posted: December 2nd, 2011, 8:00am MST

Posted: December 1st, 2011, 8:00am MST

Posted: December 1st, 2011, 8:00am MST

Posted: November 29th, 2011, 8:00am MST

Posted: November 29th, 2011, 8:00am MST

Posted: November 28th, 2011, 8:00am MST

Posted: November 25th, 2011, 8:00am MST

Posted: November 23rd, 2011, 8:00am MST

Posted: November 23rd, 2011, 8:00am MST

Posted: November 21st, 2011, 8:00am MST

Posted: November 21st, 2011, 8:00am MST

Posted: November 18th, 2011, 8:00am MST

Posted: November 17th, 2011, 8:00am MST

Posted: November 16th, 2011, 8:00am MST

Posted: November 16th, 2011, 8:00am MST

Posted: November 15th, 2011, 8:00am MST